HoLVPTM

Holmium Laser Vaporization of the Prostate (HoLVP) is a safe and effective BPH treatment option that provides immediate symptom relief with few complications6.

The holmium laser penetrates just enough to precisely and quickly vaporize tissue without causing deeper thermal injury, coagulation necrosis or collateral damage7.

HoLVP is a virtually bloodless, out-patient procedure that offers quick recovery time and a rapid return to normal activity7.

HoLVPTM Is Durable At 7 Years

  • holap11.pngDurable outcomes over 7 years1
  • 47% decrease in AUA symptom score
  • 83% improvement in flow rate
  • 15% reoperation rate comparable to TURP
  • Lumenis Surgical – Prostate vaporization

HoLVPTM Results Are Comparable to TURP

  • holvp1.jpgHoLVP and TURP outcomes equivalent at 12 months
  • Catheterization times for HoLVP shorter than TURP2
  • Hospital stay for HoLVP shorter than TURP
  • No post-operative irrigation required with HoLVP
  • No initial dysuria
  • Lumenis Surgical – Prostate vaporization

High Power Holmium Ideal for BPH

holap44.pngThe holmium laser penetrates just enough to precisely and quickly vaporize tissue without causing deeper thermal injury, coagulation necrosis or collateral damage.

References
Tan A, et al. Long-term Results of High-power Holmium Laser Vaporization (Ablation) of the Prostate., BJU International, 92:707-9, 2003
Mottet N, et al. Randomized Comparison of Transurethral Electroresection of Holmium:YAG Laser Vaporization for Symptomatic Benign Hyperplaysia. J Endo, 13:127-120, Mar 1999
Kruntz RM. Current Role of Lasers in the Treatment of Benign Prostatic Hyperplasia. Eur Urol, 49:961-969, Jun 2006
Gilling, et al. Use of Holmium Laser in the Treatment of Benign Prostatic Hyperplasia. J Endo, 10(5):459-461, Oct 1996
The Canadian Journal of Urology, Oct 2007, Dr. Derek Matoka & Dr. Timothy Averch
American Urological Association Guideline: Management of Benign Prostatic Hyperplasia (BPH), 2010
Tholomier C, Valdivieso R, Hueber P-A, Zorm KC. Photoselective laser ablation of the prostate: a review of the current 2015 tissue ablation options. Can J Urol 2015;22(Suppl 1):45-52

Enquire about this product

Thank you. Your enquiry has been sent. We will respond as soon as possible.

Sorry. An error occurred and your message has not been sent. Please try again or alternatively please contact us by phone.

Request Demo Request Quotation Request Further Information